Scinai Immunotherapeutics... (SCNI)
NASDAQ: SCNI
· Real-Time Price · USD
2.27
-0.22 (-8.84%)
At close: Jul 02, 2025, 3:59 PM
2.20
-3.08%
After-hours: Jul 02, 2025, 07:51 PM EDT
-8.84% (1D)
| Bid | 2.18 |
| Market Cap | 1.94M |
| Revenue (ttm) | 1.24M |
| Net Income (ttm) | 4.35M |
| EPS (ttm) | 2.4 |
| PE Ratio (ttm) | 0.95 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.28 |
| Volume | 332,243 |
| Avg. Volume (20D) | 380,136 |
| Open | 2.39 |
| Previous Close | 2.49 |
| Day's Range | 2.12 - 2.42 |
| 52-Week Range | 1.90 - 8.92 |
| Beta | 2.09 |
About SCNI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCNI
Website n/a
4 weeks ago
+28.97%
Scinai Immunotherapeutics shares are trading highe...
Unlock content with
Pro Subscription
4 months ago
+3.89%
Scinai shares are trading higher after the company signed a $10 million standby equity agreement and retained control over stock sales to Yorkville.
10 months ago · seekingalpha.com
Scinai Immunotherapeutics Ltd. (SCNI) Q2 2024 Earnings Call TranscriptScinai Immunotherapeutics Ltd. (NASDAQ:SCNI ) Q2 2024 Results Conference Call August 20, 2024 11:00 AM ET Company Participants Liat Halpert - Head of Business Development Amir Reichman - CEO Liat Halp...
